SCHEMBL10094171

SCHEMBL10094171

CC(C)c1ccccc1Nc1cccc(NS(C)(=O)=O)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ POLB P06746 1/20 0.47
▸ KEAP1 Q14145 2/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ PLA2G7 Q13093 1/20 0.41
▸ CCR4 P51679 1/20 0.40
▸ CXCL8 P10145 1/20 0.40
▸ GLO1 Q04760 2/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MAPK10 P53779 2/20 0.38
▸ SCN9A Q15858 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ NFE2L2 Q16236 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ PIK3CG P48736 1/20 0.37
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607024 0.78 L3MBTL1 (1.00) L3MBTL1POLBKEAP1NPC1PLA2G7
SCHEMBL10094185 0.76 XIAP (0.45) L3MBTL1POLBCCR4CXCL8SCN9A
SCHEMBL10094540 0.73 HSD11B1 (0.53) L3MBTL1KEAP1GLO1ALOX15HTT
SCHEMBL10094215 0.72 CCR4 (0.44) L3MBTL1CCR4EGFRPIK3CAPIK3CB
SCHEMBL10094163 0.70 MEN1 (0.66) L3MBTL1POLBNPC1CCR4MAPK10
SCHEMBL3958491 0.70 L3MBTL1 (0.57) L3MBTL1POLBNPC1CCR4EGFR
SCHEMBL1333471 0.70 SCN9A (0.46) L3MBTL1KEAP1GLO1ALOX15HTT
SCHEMBL29464237 0.70 SCN9A (0.46) L3MBTL1KEAP1GLO1ALOX15HTT
SCHEMBL24858605 0.69 L3MBTL1 (0.69) L3MBTL1POLBKEAP1NPC1PLA2G7
SCHEMBL10094332 0.69 L3MBTL1 (0.74) L3MBTL1POLBKEAP1NPC1PLA2G7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 — — US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233897-A1 Potassium Channel Inhibitors KCNJ2, KCNQ2, KCNH2 L3MBTL1 519/4885POLB 4819/4885KEAP1 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback